DDX23, as a substrate protein, was reported to interact with SDC4 with the aid of bufalin, a small molecule anticancer drug, to induce inactivated matrix metalloproteinases and elevated p38/JNK MAPKs phosphorylation in hepatocellular carcinoma [23]. The gene discussed is SDC4; the disease is hepatocellular carcinoma.